Skip to content

Clinical trials

Completed Primary Myelofibrosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Status: Completed Country / region: United Kingdom Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20072
20091
20101
20112
20121
20135
20142
20152
20174
20181
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Celgene4
Sierra Oncology LLC - a GSK company3
AbbVie2
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2
CTI BioPharma1
Constellation Pharmaceuticals1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Fred Hutchinson Cancer Center1
Geron Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis27
Myeloproliferative Disorders9
Thrombocythemia, Essential9
Polycythemia Vera7
Bone Marrow Diseases4
Anemia3
Hematologic Diseases3
Blood Coagulation Disorders2
Blood Platelet Disorders2
Hemorrhagic Disorders2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.